Skip to Main Content

Paper Details

Myosteatosis at diagnosis is adversely associated with 2-year survival in women with estrogen receptor-negative metastatic breast cancer.
Breast Cancer Res Treat
5
2021
Author NameAffiliation
Cara JoyceLoyola University Chicago
  • 1 - 1

Datasets

Release 1.2